Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still haven’t finished.
People Are Already Taking This Unapproved New Weight-Loss Drug
Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still haven’t finished.
Watch out high-end models, these noise-canceling headphones are an amazing value.
New records about the infamous sex offender are released seemingly every week. Here’s a quick rundown of who’s releasing the Epstein documents, what they contain—and what they’re releasing next.
As the US government rapidly merges data from across agencies in service of draconian immigration policies, citizens increasingly risk being caught up as well.
The names of two partial owners of firms linked to the Salt Typhoon hacker group also appeared in records for a Cisco training program—years before the group targeted Cisco’s devices in a spy campaign.
Eufy’s last-season robot vacuum-mop has a crazy price cut. Grab it before it’s gone.
Most Democratic-led states will continue to recommend the hepatitis B vaccine at birth, despite a CDC advisory panel’s vote against it.
True Classic Tees is running holiday “flash deals” with some of the best prices we’ve seen in months.
With support from Microsoft, Stripe, and Shopify, Running Tide billed itself as on the cutting edge of carbon removal. In the end, it resorted to dumping thousands of tons of wood chips in the sea.
Despite all the worries about the economy, laptop prices have never been lower. But in 2026, all of that could change.